These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 23929950)
21. [Finding of O-mannosyl glycan in mammals and congenital muscular dystrophies due to glycosylation defects]. Endo T Yakugaku Zasshi; 2003 Oct; 123(10):825-35. PubMed ID: 14577328 [TBL] [Abstract][Full Text] [Related]
22. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression. Hu H; Li J; Zhang Z; Yu M Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441 [TBL] [Abstract][Full Text] [Related]
23. Mouse large can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding. Patnaik SK; Stanley P J Biol Chem; 2005 May; 280(21):20851-9. PubMed ID: 15788414 [TBL] [Abstract][Full Text] [Related]
24. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues. Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275 [TBL] [Abstract][Full Text] [Related]
25. Muscle-specific expression of LARGE restores neuromuscular transmission deficits in dystrophic LARGE(myd) mice. Gumerson JD; Davis CS; Kabaeva ZT; Hayes JM; Brooks SV; Michele DE Hum Mol Genet; 2013 Feb; 22(4):757-68. PubMed ID: 23222475 [TBL] [Abstract][Full Text] [Related]
26. The inside and out of dystroglycan post-translational modification. Moore CJ; Winder SJ Neuromuscul Disord; 2012 Nov; 22(11):959-65. PubMed ID: 22770978 [TBL] [Abstract][Full Text] [Related]
28. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome. Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570 [TBL] [Abstract][Full Text] [Related]
29. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V. Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095 [TBL] [Abstract][Full Text] [Related]
30. Deficiency of alpha-dystroglycan in muscle-eye-brain disease. Kano H; Kobayashi K; Herrmann R; Tachikawa M; Manya H; Nishino I; Nonaka I; Straub V; Talim B; Voit T; Topaloglu H; Endo T; Yoshikawa H; Toda T Biochem Biophys Res Commun; 2002 Mar; 291(5):1283-6. PubMed ID: 11883957 [TBL] [Abstract][Full Text] [Related]
31. Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1. Pereira NA; Pu HX; Goh H; Song Z J Biol Chem; 2014 May; 289(21):14762-70. PubMed ID: 24733390 [TBL] [Abstract][Full Text] [Related]
32. Localization and functional analysis of the LARGE family of glycosyltransferases: significance for muscular dystrophy. Brockington M; Torelli S; Prandini P; Boito C; Dolatshad NF; Longman C; Brown SC; Muntoni F Hum Mol Genet; 2005 Mar; 14(5):657-65. PubMed ID: 15661757 [TBL] [Abstract][Full Text] [Related]
33. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy. Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726 [TBL] [Abstract][Full Text] [Related]
34. Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. Kanagawa M; Michele DE; Satz JS; Barresi R; Kusano H; Sasaki T; Timpl R; Henry MD; Campbell KP FEBS Lett; 2005 Aug; 579(21):4792-6. PubMed ID: 16098969 [TBL] [Abstract][Full Text] [Related]
35. Matriglycan: a novel polysaccharide that links dystroglycan to the basement membrane. Yoshida-Moriguchi T; Campbell KP Glycobiology; 2015 Jul; 25(7):702-13. PubMed ID: 25882296 [TBL] [Abstract][Full Text] [Related]
36. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Yoshida A; Kobayashi K; Manya H; Taniguchi K; Kano H; Mizuno M; Inazu T; Mitsuhashi H; Takahashi S; Takeuchi M; Herrmann R; Straub V; Talim B; Voit T; Topaloglu H; Toda T; Endo T Dev Cell; 2001 Nov; 1(5):717-24. PubMed ID: 11709191 [TBL] [Abstract][Full Text] [Related]
38. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein. Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668 [TBL] [Abstract][Full Text] [Related]
39. Fer kinase regulates cell migration through α-dystroglycan glycosylation. Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358 [TBL] [Abstract][Full Text] [Related]
40. N-acetylglucosamine modification in the lumen of the endoplasmic reticulum. Ogawa M; Sawaguchi S; Furukawa K; Okajima T Biochim Biophys Acta; 2015 Jun; 1850(6):1319-24. PubMed ID: 25791024 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]